77 related articles for article (PubMed ID: 21946883)
1. Quetiapine-associated cardiomyopathy.
Coffey S; Williams M
N Z Med J; 2011 Jun; 124(1337):105-7. PubMed ID: 21946883
[No Abstract] [Full Text] [Related]
2. [Abuse of quetiapine. Two addicted patients with borderline personality disorder].
Galyuk TM; de Backer G; de Jong CA; Beers E; Loonen AJ
Ned Tijdschr Geneeskd; 2009 Apr; 153(14):674-6. PubMed ID: 19425328
[No Abstract] [Full Text] [Related]
3. Fatal cardiomyopathy due to quetiapine.
Bush A; Burgess C
N Z Med J; 2008 Jan; 121(1268):U2909. PubMed ID: 18256721
[No Abstract] [Full Text] [Related]
4. Dose-dependent constipation with higher doses of quetiapine: a case series.
Raedler TJ; Reimer J; Wiedemann K
Int Clin Psychopharmacol; 2007 Jul; 22(4):244-6. PubMed ID: 17519649
[TBL] [Abstract][Full Text] [Related]
5. Quetiapine in patients with borderline personality disorder: an open-label trial.
Adityanjee ; Romine A; Brown E; Thuras P; Lee S; Schulz SC
Ann Clin Psychiatry; 2008; 20(4):219-26. PubMed ID: 19034754
[TBL] [Abstract][Full Text] [Related]
6. De novo induction of obsessive-compulsive symptoms with quetiapine in a patient with borderline personality disorder.
Alexander J
Aust N Z J Psychiatry; 2009 Dec; 43(12):1185. PubMed ID: 20001420
[No Abstract] [Full Text] [Related]
7. The effect of add-on treatment with quetiapine on measures of depression, aggression, irritability and suicidal tendencies in children and adolescents.
Podobnik J; Foller Podobnik I; Grgic N; Marcinko D; Pivac N
Psychopharmacology (Berl); 2012 Apr; 220(3):639-41. PubMed ID: 22173852
[No Abstract] [Full Text] [Related]
8. Long-term effectiveness of quetiapine in bipolar disorder in a clinical setting.
Ketter TA; Brooks JO; Hoblyn JC; Holland AA; Nam JY; Culver JL; Marsh WK; Bonner JC
J Psychiatr Res; 2010 Oct; 44(14):921-9. PubMed ID: 20378127
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder.
Van den Eynde F; Senturk V; Naudts K; Vogels C; Bernagie K; Thas O; van Heeringen C; Audenaert K
J Clin Psychopharmacol; 2008 Apr; 28(2):147-55. PubMed ID: 18344724
[TBL] [Abstract][Full Text] [Related]
10. [Quetiapine and the potential for abuse].
Aa E; Helland A; Spigset O
Tidsskr Nor Laegeforen; 2012 Aug; 132(14):1619-20. PubMed ID: 22875127
[TBL] [Abstract][Full Text] [Related]
11. High-dose quetiapine and photopsia.
Hazra M; Culo S; Mamo D
J Clin Psychopharmacol; 2006 Oct; 26(5):546-7. PubMed ID: 16974209
[No Abstract] [Full Text] [Related]
12. Quetiapine: efficacy, tolerability and safety in schizophrenia.
Miodownik C; Lerner V
Expert Rev Neurother; 2006 Jul; 6(7):983-92. PubMed ID: 16831113
[TBL] [Abstract][Full Text] [Related]
13. Urinary retention following repeated high-dose quetiapine.
Sokolski KN; Brown BJ; Melden M
Ann Pharmacother; 2004 May; 38(5):899-900. PubMed ID: 15039480
[No Abstract] [Full Text] [Related]
14. High-dose loading with extended release quetiapine.
Chae BJ
J Clin Pharm Ther; 2010 Aug; 35(4):487-9. PubMed ID: 20831551
[TBL] [Abstract][Full Text] [Related]
15. Comment on: low-dose quetiapine-induced severe rhabdomyolysis.
Ceri M; Unverdi S; Altay M; Duranay M
Ren Fail; 2011; 33(4):463-4. PubMed ID: 21529278
[No Abstract] [Full Text] [Related]
16. Does quetiapine have mood altering properties?
Mishra A; Moore PB; Hobbs R
J Psychopharmacol; 2004 Jun; 18(2):281-4. PubMed ID: 15260919
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia.
Lee KU; Jeon YW; Lee HK; Jun TY
Hum Psychopharmacol; 2009 Aug; 24(6):447-52. PubMed ID: 19606454
[TBL] [Abstract][Full Text] [Related]
18. An open-label trial of quetiapine for antipsychotic-induced sexual dysfunction.
Byerly MJ; Lescouflair E; Weber MT; Bugno RM; Fisher R; Carmody T; Varghese F; Rush AJ
J Sex Marital Ther; 2004; 30(5):325-32. PubMed ID: 15672600
[TBL] [Abstract][Full Text] [Related]
19. A commentary on "A young man with acute dilated cardiomyopathy associated with methylphenidate".
Ghanizadeh A
Vasc Health Risk Manag; 2009; 5(2):525. PubMed ID: 19554092
[No Abstract] [Full Text] [Related]
20. Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression.
Baune BT; Caliskan S; Todder D
Hum Psychopharmacol; 2007 Jan; 22(1):1-9. PubMed ID: 17191266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
